Jacobs Levy Equity Management’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-103,926
Closed -$1.08M 1226
2022
Q2
$1.08M Sell
103,926
-804,139
-89% -$5.98M 0.01% 737
2022
Q1
$8.02M Buy
908,065
+239,373
+36% +$1.81M 0.05% 340
2021
Q4
$4.63M Sell
668,692
-68,189
-9% -$1M 0.03% 442
2021
Q3
$9.14M Sell
736,881
-86,324
-10% -$1.24M 0.06% 316
2021
Q2
$15M Buy
823,205
+14,236
+2% +$283K 0.1% 229
2021
Q1
$16.9M Sell
808,969
-15,552
-2% -$328K 0.13% 201
2020
Q4
$14.7M Sell
824,521
-7,867
-0.9% -$118K 0.13% 185
2020
Q3
$9.44M Buy
832,388
+166,558
+25% +$2.06M 0.1% 218
2020
Q2
$9.07M Buy
665,830
+208,247
+46% +$2.87M 0.1% 234
2020
Q1
$5.95M Buy
457,583
+260,776
+133% +$4.65M 0.08% 263
2019
Q4
$3.97M Buy
196,807
+167,527
+572% +$4.07M 0.04% 418
2019
Q3
$754K Buy
+29,280
New +$718K 0.01% 660

Other funds holding RDUS

Jacobs Levy Equity Management's RDUS Position: Q3 2022 in Review

Jacobs Levy Equity Management sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 103,926 shares — an estimated $1.08M sold.

Jacobs Levy Equity Management first reported a position in RDUS in Q3 2019 and held it in 12 quarters. The position peaked at $16.9M in Q1 2021. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

  • Jacobs Levy Equity Management reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 103,926 Radius Health, Inc. shares in Q3 2022, an estimated $1.08M.
  • Jacobs Levy Equity Management first reported a position in Radius Health, Inc. in Q3 2019 and held it in 12 quarters.
  • Jacobs Levy Equity Management's Radius Health, Inc. position peaked at $16.9M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2022, filed 15 Nov 2022.